Gainers
- Akcea Therapeutics Inc AKCA shares jumped 31.3% to close at $19.87 on Monday after the company announced it would receive a $125 million upfront payment from Pfizer for the exclusive licensing of AKCEA-ANGPTL3-L.
- Sienna Biopharmaceuticals Inc SNNA gained 19.8% to close at $0.3010 after the company filed 510(k) with the FDA for SNA-001.
- Livongo Health Inc LVGO gained 18.4% to close at $20.50 after the company won a contract from the federal employees health benefits program for diabetes. The company expects the contract to add $50 to $60 million in revenue over the next two years.
- Pfenex Inc. PFNX rose 15.5% to close at $8.62 after receiving U.S. FDA approval for PF708 to treat osteoporosis.
- International Seaways, Inc. INSW rose 14.8% to close at $23.83. International Seaways sold its 49.9% interest in Qatar Gas Transport to Nakilat for $123 million in cash.
- Advaxis, Inc. ADXS gained 13.4% to close at $0.3684 after the company announced an update to its prolonged survival data in the Phase 1/2 of the ADXS-PSA trial.
- BroadVision, Inc. BVSN rose 13.1% to close at $2.8500.
- Diamond S Shipping Inc. DSSI gained 13% to close at $13.86.
- Aethlon Medical, Inc. AEMD climbed 12.2% to close at $0.2750 after the company announced it received an FDA approval for its IDE for Oncology Indications.
- Teekay Corporation TK gained 11.4% to close at $4.12.
- The Pennant Group, Inc. PNTG climbed 11.3% to close at $17.81.
- One Stop Systems, Inc. OSS gained 10.8% to close at $3.07.
- Nordic American Tankers Limited NAT rose 10.4% to close at $3.08.
- The ONE Group Hospitality, Inc. STKS gained 10% to close at $2.85.
- Overstock.com, Inc. OSTK climbed 9.8% to close at $11.22.
- Signet Jewelers Limited SIG rose 9.8% to close at $17.84.
- Navios Maritime Acquisition Corporation NNA gained 9.5% to close at $7.61.
- Nephros, Inc. NEPH gained 8.7% to close at $10.00 after the company raised FY2019 sales guidance.
- Tsakos Energy Navigation Limited TNP gained 8.4% to close at $3.34.
- CrowdStrike Holdings, Inc. CRWD gained 7.7% to close at $68.78.
- Gold Resource Corporation GORO climbed 5.9% to close at $3.41.
- RingCentral, Inc. RNG shares rose 5.8% to close at $172.72 after gaining 28.04% on Friday. JP Morgan upgraded RingCentral from Neutral to Overweight and raised the price target from $143 to $225.
- Mammoth Energy Services, Inc. TUSK shares jumped 5.6% to close at $2.2500.
Check out these big penny stock gainers and losers
Losers
- Sorrento Therapeutics Inc SRNE dropped 25.5% to close at $1.78 after JMP Securities initiated coverage on the stock with an Outperform rating and a price target of $21 per shares.
- NGM Biopharmaceuticals, Inc. NGM shares dipped 20.4% to close at $10.78 after reporting interim results from ongoing 24-week Phase 2 study evaluating aldafermin in patients with NASH.
- FuelCell Energy Inc FCEL dropped 12.2% to close at $0.3191 after the company filed for a common stock offering of up to 38 million shares.
- DiaMedica Therapeutics Inc. DMAC dipped 11.3% to close at $2.05.
- Capricor Therapeutics, Inc. CAPR fell 10.4% to close at $3.0100 after the company issued an update on its HOPE-2 study of CAP-1002.
- PaySign, Inc. PAYS dropped 10.3% to close at $10.36.
- DPW Holdings, Inc. DPW shares declined 9.9% to close at $1.9200.
- Sequential Brands Group Inc SQBG shares fell 8.8% to close at $0.2371 after the company announced plans to explore strategic alternatives. The company also disclosed that its Karen Murray is stepping down as CEO.
- Perma-Fix Environmental Services, Inc. PESI dipped 8.8% to close at $4.76.
- BP Prudhoe Bay Royalty Trust BPT shares dropped 8.4% to close at $8.09.
- Radius Health, Inc. RDUS dipped 7.9% to close at $23.71.
- DBV Technologies S.A.. DBVT fell 7.7% to close at $8.22.
- Avadel Pharmaceuticals plc AVDL fell 6.4% to close at $3.64. Avadel reported the resignation of Kevin Kotler from Board of Directors.
- HEXO Corp. HEXO fell 6.4% to close at $3.80 after the company announced the resignation of its Chief Financial Officer, Michael Monahan.
- Intersect ENT Inc XENT shares fell 3.6% to close at $16.36 after the company's ASCENT trial did not meet its primary endpoint.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: EnergyMovers From YesterdayOil & Gas Storage & TransportationTop GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral